The Journal of Urology
Volume 182, Issue 1 , Pages 139-144, July 2009

Length of Positive Surgical Margin After Radical Prostatectomy as a Predictor of Biochemical Recurrence

  • Sergey Shikanov

      Affiliations

    • Nothing to disclose.
    • ,
  • Jie Song

      Affiliations

    • Nothing to disclose.
    • ,
  • Cassandra Royce

      Affiliations

    • Nothing to disclose.
    • ,
  • Hikmat Al-Ahmadie

      Affiliations

    • Nothing to disclose.
    • ,
  • Kevin Zorn

      Affiliations

    • Financial interest and/or other relationship with Intuitive Surgical and SurgRx, Inc.
    • ,
  • Gary Steinberg

      Affiliations

    • Financial interest and/or other relationship with Vysis, Bioniche and Spectrum.
    • ,
  • Gregory Zagaja

      Affiliations

    • Financial interest and/or other relationship with Intuitive Surgical.
    • ,
  • Arieh Shalhav

      Affiliations

    • Nothing to disclose.
    • ,
  • Scott Eggener

      Affiliations

    • Nothing to disclose.
    • Corresponding Author InformationCorrespondence: 5841 S. Maryland Ave., MC 6038, Chicago, Illinois 60637 (telephone: 773-702-5195; FAX: 773-702-1001)

University of Chicago, Chicago, Illinois

Received 15 December 2008 published online 18 May 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Editor's Note: This article is the third of 5 published in this issue for which category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 402 and 403.

 For another article on a related topic see page 317.

PII: S0022-5347(09)00577-1

doi:10.1016/j.juro.2009.02.139

Refers to article:

  • Phase II Trial of Capecitabine and Weekly Docetaxel for Metastatic Castrate Resistant Prostate Cancer , 18 May 2009

    Ulka N. Vaishampayan, Shanthi Marur, Lance K. Heilbrun, Michael L. Cher, Brenda Dickow, Daryn W. Smith, Samir A. Al Hasan, James Eliason
    The Journal of Urology July 2009 (Vol. 182, Issue 1, Pages 317-323)

The Journal of Urology
Volume 182, Issue 1 , Pages 139-144, July 2009

Article Tools

* Image Usage & Resolution